- Filed
- Aug 13, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Aug 11, 2021 | 2.93M sh |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $15.74M |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $32.35M |
| Cash And Equivalents | Q2 2021 · Jun 30, 2020 | $29.3M |
| Cash And Equivalents | Q2 2021 · Dec 31, 2019 | $37.74M |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $206.97M |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $195.63M |
| Total Assets | Q2 2021 · Jun 30, 2021 | $249.77M |
| Total Assets | Q2 2021 · Dec 31, 2020 | $237.13M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $33.63K |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $60.39K |
| Cost Of Revenue | Q2 2021 · Jun 30, 2020 | $36.57K |
| Cost Of Revenue | Q2 2021 · Jun 30, 2020 | $69.54K |
| Shares Diluted restated | Q2 2021 · Jun 30, 2020 | 2.78M sh |
| Shares Diluted restated | Q2 2021 · Jun 30, 2020 | 2.79M sh |
| Capex | Q2 2021 · Jun 30, 2020 | $294.39K |
| Operating Cash Flow | Q2 2021 · Jun 30, 2020 | −$15.61M |
| Stockholders Equity | Q2 2021 · Jun 30, 2020 | $38.74M |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | $37.91M |
| Stockholders Equity | Q2 2021 · Dec 31, 2019 | $23.84M |
| Eps Diluted restated | Q2 2021 · Jun 30, 2020 | $0.26 |
| Eps Diluted restated | Q2 2021 · Jun 30, 2020 | $0.18 |
| Eps Basic restated | Q2 2021 · Jun 30, 2020 | $0.26 |
| Eps Basic restated | Q2 2021 · Jun 30, 2020 | $0.18 |
| Net Income | Q2 2021 · Jun 30, 2020 | $723.99K |
| Net Income | Q2 2021 · Jun 30, 2020 | $497.94K |